Stay updated on Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed, updating the page's version metadata without changes to the core study details.
    Difference
    0.1%
    Check dated 2026-04-16T10:04:03.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Version updated from v3.4.3 to v3.5.0 on the page, indicating a platform-level update without changes to study data or content.
    Difference
    0.1%
    Check dated 2026-03-18T16:59:14.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added, replacing the previous v3.4.2 in the revision history.
    Difference
    0.1%
    Check dated 2026-03-11T16:39:40.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Results section updated with data on dose-limiting toxicities, timing, and RECIST responses. Exploratory biomarker endpoints were removed.
    Difference
    3%
    Check dated 2026-02-18T04:24:21.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1 along with the funding/operating-status notice. There are no visible changes to the study details or results.
    Difference
    0.5%
    Check dated 2026-02-11T02:32:19.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Administrative notices were added: a government funding lapse notice and an update to version 3.4.1. The prior version 3.4.0 was removed.
    Difference
    0.5%
    Check dated 2026-02-03T23:25:13.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.